Get the Stockscreener App
40.47
4.10%
-1.73
After Hours:
40.42
-0.05
-0.12%
Hims Hers Health Inc stock is traded at $40.47, with a volume of 15.71M.
It is down -4.10% in the last 24 hours and up +50.45% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
See More
Previous Close:
$42.20
Open:
$41.9
24h Volume:
15.71M
Relative Volume:
0.98
Market Cap:
$8.84B
Revenue:
$1.24B
Net Income/Loss:
$101.26M
P/E Ratio:
91.98
EPS:
0.44
Net Cash Flow:
$149.62M
1W Performance:
+19.17%
1M Performance:
+50.45%
6M Performance:
+139.75%
1Y Performance:
+329.62%
1-Day Range:
$39.27
$43.16
1-Week Range:
$33.68
$44.43
52-Week Range:
$9.1411
$44.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
40.47 | 8.84B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
168.88 | 396.00B | 84.35B | 15.48B | 15.47B | 6.28 |
|
UL
Unilever Plc Adr
|
58.07 | 144.70B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
85.68 | 70.00B | 20.10B | 2.89B | 3.55B | 3.52 |
|
KMB
Kimberly Clark Corp
|
128.69 | 42.70B | 20.06B | 2.55B | 2.51B | 7.55 |
|
KVUE
Kenvue Inc
|
19.80 | 37.96B | 15.46B | 1.06B | 1.40B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Hims & Hers Health (NYSE:HIMS) Stock Price Up 4.5%Still a Buy? - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Stake Lifted by Means Investment CO. Inc. - MarketBeat
Analysts Set Hims & Hers Health, Inc. (NYSE:HIMS) Target Price at $25.13 - MarketBeat
Hims Telehealth Company Under Fire For Super Bowl Ad - Science 2.0
Pacer Advisors Inc. Takes Position in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims’ Super Bowl Ad Hit for ‘Misleading’ Weight-Loss Claims - Bloomberg
Hims & Hers Super Bowl ad slammed for ‘misleading’ claims - Modern Healthcare
Hims & Hers Health (NYSE:HIMS) Trading Up 4.5%Here's What Happened - MarketBeat
Hims & Hers Health down as Super Bowl ad draws controversy (HIMS:NYSE) - Seeking Alpha
When (HIMS) Moves Investors should Listen - Stock Traders Daily
Industry group asks FDA to ‘take action’ against Hims & Hers Super Bowl ad - TipRanks
Kercheville Advisors LLC Makes New $470,000 Investment in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health (NYSE:HIMS) Sets New 12-Month HighStill a Buy? - MarketBeat
Pharma group slams Hims & Hers over Super Bowl GLP-1 ad - pharmaphorum
Short Interest in Hims & Hers Health, Inc. (NYSE:HIMS) Expands By 21.3% - MarketBeat
Andrew Dudum Sells 100,000 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock - MarketBeat
Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 4,153 Shares of Stock - MarketBeat
Hims & Hers Health, Inc. (HIMS) Exceeds Market Returns: Some Facts to Consider - MSN
Wall Street Sounds Alarm On Hims & Hers Amid Ro-Eli Lilly Zepbound Tie-Up: Retail Shrugs It Off - MSN
Why Jim Cramer Says Hims & Hers Health Could Skyrocket – Don't Miss Out! - Reporteros del Sur
Jim Cramer on Hims & Hers Health, Inc. (HIMS): ‘This Stock Is A Short Squeeze’ - Insider Monkey
Jim Cramer Shed Light on These 8 Stocks Recently - Insider Monkey
Is Hims & Hers Health, Inc. (HIMS) Among the Best Beauty Stocks to Buy According to Hedge Funds? - Insider Monkey
KBC Group NV Has $205,000 Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
EMC Capital Management Sells 8,273 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Perigon Wealth Management LLC Invests $337,000 in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - MSN
Hims & Hers Launches Health Collective and Community Member Council -February 04, 2025 at 09:20 am EST - Marketscreener.com
Hims & Hers Launches Health Collective and Community Member Council - The Bakersfield Californian
Hims Unveils Game-Changing Customer Programs: Early Product Access and Direct Platform Input - StockTitan
Market Participants Recognise Hims & Hers Health, Inc.'s (NYSE:HIMS) Revenues Pushing Shares 46% Higher - Simply Wall St
Hims & Hers Health (NYSE:HIMS) Sets New 1-Year HighWhat's Next? - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Given Average Rating of “Hold” by Brokerages - Defense World
Baader Bank Aktiengesellschaft Cuts Stake in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025 - Marketscreener.com
Hims & Hers Q4 Earnings: Key Date Revealed Plus Major Conference Appearance - StockTitan
Hims & Hers Health Inc. (HIMS): Among The Stocks That Started The Year On A High - MSN
Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs - Fortune
Hims & Hers Health Unusual Options Activity For February 03 - Benzinga
February 2025 US Stocks That May Be Trading Below Estimated Value - Simply Wall St
Why Hims & Hers Health (HIMS) Is Among the Best Booming Stocks to Invest in Now? - Insider Monkey
Thinner Amid Gluttony? Hims & Hers Debut First SB Ads For Weight-Loss Drugs 01/29/2025 - MediaPost Communications
Hims & Hers up 18% amid optimism for compounders with Makary FDA pick - MSN
Genesee Capital Advisors LLC Purchases New Stake in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Why Hims & Hers Health (HIMS) Skyrocketed on Friday? - Insider Monkey
12 Best Booming Stocks to Invest in Now - Insider Monkey
HIMS stock soars to all-time high, reaching $35.07 - MSN
Hims & Hers Hopes Super Bowl Commercial About Obesity Stands Apart From Pack of Snacks - AOL
HIMS Shares Seeing Buy the Rumor Rally, This is Their Target - Money Morning
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):